83 related articles for article (PubMed ID: 1474543)
41. Autofluorescence in indomethacin-induced gastric mucosal lesions in rats.
Murata Y; Matsui H; Hirano KI; Kondo Y; Yanaka A; Nakahara A; Tanaka N; Muto H
J Gastroenterol; 2000; 35(7):510-7. PubMed ID: 10905358
[TBL] [Abstract][Full Text] [Related]
42. NSAIDS and the microcirculation of the stomach.
Kawano S; Tsuji S; Sato N; Kamada T
Gastroenterol Clin North Am; 1996 Jun; 25(2):299-315. PubMed ID: 9229574
[TBL] [Abstract][Full Text] [Related]
43. Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms.
Fornai M; Colucci R; Antonioli L; Awwad O; Ugolini C; Tuccori M; Fulceri F; Natale G; Basolo F; Blandizzi C
Pharmacol Res; 2011 Jan; 63(1):59-67. PubMed ID: 20969958
[TBL] [Abstract][Full Text] [Related]
44. [Nabumetone, a new nonsteroidal antiinflammatory agent: clinical prospects].
Nasonov EL; Nasonova SV
Klin Med (Mosk); 1996; 74(8):13-6. PubMed ID: 9036198
[No Abstract] [Full Text] [Related]
45. Nonsteroidal antiinflammatory drug use in patients receiving warfarin: emphasis on nabumetone.
Hilleman DE; Mohiuddin SM; Lucas BD
Am J Med; 1993 Aug; 95(2A):30S-34S. PubMed ID: 8357000
[TBL] [Abstract][Full Text] [Related]
46. Transdermal nitroglycerin prevents nonsteroidal anti-inflammatory drug gastropathy.
Barrachina MD; Calatayud S; Canet A; Bello R; Díaz de Rojas F; Guth PH; Esplugues JV
Eur J Pharmacol; 1995 Aug; 281(2):R3-4. PubMed ID: 7589195
[No Abstract] [Full Text] [Related]
47. Comparative effects of indomethacin and nabumetone on urine and electrolyte output in conscious rats.
bin Long I; Singh HJ; Rao GJ
J Pharmacol Sci; 2005 Nov; 99(3):272-6. PubMed ID: 16293937
[TBL] [Abstract][Full Text] [Related]
48. Progress in Arthritis Therapy: Nabumetone Investigators' Meeting. Proceedings. Scottsdale, Arizona, September 27-28, 1991.
J Rheumatol Suppl; 1992 Nov; 36():1-91. PubMed ID: 1474528
[No Abstract] [Full Text] [Related]
49. Interaction between nabumetone--a new non-steroidal anti-inflammatory drug--and the haemostatic system ex vivo.
al Balla S; al Momen AK; al Arfaj H; al Sugair S; Gader AM
Haemostasis; 1990; 20(5):270-5. PubMed ID: 2289708
[TBL] [Abstract][Full Text] [Related]
50. Nabumetone. Evidence for the lack of enterohepatic circulation of the active metabolite 6-MNA in humans.
Brett MA; Buscher G; Ellrich E; Greb WH; Kurth HJ; Rülander G; Schmerenbeck B; Haddock RE; Thawley AR
Drugs; 1990; 40 Suppl 5():67-70. PubMed ID: 2081498
[No Abstract] [Full Text] [Related]
51. Novel determination of nabumetone, a cox-2 inhibitor precursor via its 4-carboxyl-2,6-dinitrobenzene diazonium (CDNBD) derived AZO dye.
Adegoke AO; Idowu SO; Olaniyi AA
Afr J Med Med Sci; 2007 Sep; 36(3):249-57. PubMed ID: 18390065
[TBL] [Abstract][Full Text] [Related]
52. Gastric mucosal pH as a prognostic index of mortality in critically ill patients.
Lee MH
Crit Care Med; 1992 Jul; 20(7):1074-6. PubMed ID: 1617980
[No Abstract] [Full Text] [Related]
53. Do non-steroidal anti-inflammatory drugs have an effect on gastric cell turnover?
Goodlad RA
Aliment Pharmacol Ther; 1996 Apr; 10(2):215. PubMed ID: 8730254
[No Abstract] [Full Text] [Related]
54. Why are non-steroidal anti-inflammatory drugs so variable in their efficacy? A description of ion trapping.
Ellis GA; Blake DR
Ann Rheum Dis; 1993 Mar; 52(3):241-3. PubMed ID: 8484682
[No Abstract] [Full Text] [Related]
55. Continuing Developments with Nabumetone: An Investigators' Update. Proceedings of a symposium.
Am J Med; 1993 Aug; 95(2A):1S-46S. PubMed ID: 8356996
[No Abstract] [Full Text] [Related]
56. Smoking and the gastric mucosa: some additional data.
Guslandi M
Gastroenterology; 1995 Apr; 108(4):1329-30. PubMed ID: 7698607
[No Abstract] [Full Text] [Related]
57. The aging stomach.
Guslandi M
Gut; 1998 May; 42(5):757. PubMed ID: 9659177
[No Abstract] [Full Text] [Related]
58. The effect of nabumetone and indomethacin on gastric mucosal function.
Shorrock CJ; Rees WD
J Rheumatol Suppl; 1992 Nov; 36():85-8. PubMed ID: 1474543
[No Abstract] [Full Text] [Related]
59. Comparison of the effects of nabumetone with indomethacin on rat gastric mucosal 6-keto-PGF1 alpha production and on bile salt-induced changes in gastric mucosal function.
Melarange R; Rashbrook LC
J Pharm Pharmacol; 1987 Sep; 39(9):717-20. PubMed ID: 2445949
[TBL] [Abstract][Full Text] [Related]
60. Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacin.
Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
Agents Actions; 1992; Spec No():C82-3. PubMed ID: 1442340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
